Profil
Jennifer Ling Lee worked as Director-Commercial Finance at Roche Holdings, Inc. from 2010 to 2016.
She then worked as Chief Accounting Officer, VP & Controller at Standard BioTools, Inc. from 2016 to 2018.
After that, she worked as Chief Accounting Officer at Moderna, Inc. Ms. Lee holds an MBA from Golden Gate University and an undergraduate degree from San Francisco State University.
Anciens postes connus de Jennifer Ling Lee
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Comptroller/Controller/Auditor | 02/01/2020 |
| STANDARD BIOTOOLS INC. | Comptroller/Controller/Auditor | 29/03/2018 |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Corporate Officer/Principal | 01/05/2016 |
Formation de Jennifer Ling Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Health Technology |
Standard BioTools, Inc.
Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
Golden Gate University
Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
















